Clinical Trial Update: A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluated autologous T-cell transplantation with vaccine-driven expansion of anti-tumor effectors after cytoreductive therapy in metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Autologous T-cell transplantation with vaccine-driven expansion

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ewing's Sarcoma, Rhabdomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2012-06-12